Progetti FP7 coordinati da "Glaxosmithkline vaccines srl"

# progetto  anno  totale costo  contributi 
1 DEVANI Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune response 2008 5˙923˙577.00 4˙196˙460.00
2 EIMID-IAPP European Initiative for basic research in Microbiology and Infectious Diseases - IAPP 2008 2˙172˙806.00 2˙172˙806.00
3 MEGALOVAX In search of new cytomegalovirus vaccine antigens 2010 164˙958.00 164˙958.00
4 EIMID ITN European Initiative for basic research in Microbiology and Infectious Diseases 2010 2˙662˙577.00 2˙662˙577.00
5 TCDIFLU Impact of adjuvants on T cell differentiation after Influenza Vaccination analyzed at the Single Cell Level 2011 180˙084.00 180˙084.00
6 RESTAVAC Regulation of Expression of Staphylococcus aureus Vaccine Antigen Candidates 2013 179˙739.00 179˙739.00
7 SV-STAPH-VAX Structural Vaccinology to drive the design and optimization of protein antigens for a multicomponent vaccine against Staphylococcus aureus 2014 187˙414.00 187˙414.00
8 SAMUFLU Self-amplifying RNA technology applied to the development of a universal influenza vaccine 2014 187˙414.00 187˙414.00
9 DISCO A multidisciplinary Doctoral Industrial School on novel preventive strategies against E. Coli infections 2014 1˙009˙587.00 1˙009˙587.00

Altri progetti

L'Ente glaxosmithkline vaccines srl partecipato anche in questi progetti.